Request Deal Involvement
Ampersand Capital Partners to acquire the Huntsville, Alabama manufacturing facility and reagent supply business of Nektar Therapeutics for $90m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Goodwin Procter
financial advisors
UBS
legal advisors
Sidley Austin
pr advisors
LifeSci Partners
or
Principals
bidder
AMPERSAND CAPITAL PARTNERS
target
NEKTAR THERAPEUTICS (COMMERCIAL PEGYLATION REAGENT MANUFACTURING BUSINESS IN ALABAMA)
vendor
NEKTAR THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite